Skip to main content
Caplight Logo









Chemestmed

Chemestmed

Private
TartuHealthcare & Life Scienceshttps://chemestmed.com/

Last Round

Grant

Jun 10, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Chemestmed is a biotechnology company that develops small-molecule therapeutics for the treatment of cancer, neurodegenerative, and metabolic disorders by regulating RNA methylation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

epitranscriptomicssmall-molecule drugsdrug discoveryRNA methylationrna therapeuticsbiotech startupMETTL3 inhibitorsALKBH5 inhibitorsFTO inhibitorspreclinical researchtherapeutic developmentin-silico screeningdrug licensinginvestigational new drugIND

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chemestmed Comparables

Compare Chemestmed with similar companies based on industry and business-model similarity.

Chemestmed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
STORM Therapeutics
86%
Ribometrix
83%
ReviR Therapeutics
81%

Chemestmed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 10, 2026
GrantDec 19, 2024

Key People

Founding team and executive leadership

Mihkel Märtson

Chief Operating Officer

Executive Team

Chemestmed Investors

Notable investors and investment history

Chemestmed investors
InvestorRounds
European Innovation CouncilGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 231% MoM, reaching 1.7K.

  • Jun 10, 2026

    Received grant funding from the European Innovation Council.

Chemestmed Filings

Explore SEC and related filing metadata, where available.

Chemestmed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Chemestmed's valuation, stock price, and market status.

Is Chemestmed a public or private company?

Chemestmed is a private company.

What is the current stock price of Chemestmed?

Chemestmed is a private company with no public stock price. Caplight tracks Chemestmed's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Chemestmed worth (valuation)?

Valuation information for Chemestmed is not publicly available.

Can I buy Chemestmed stock?

Chemestmed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Chemestmed's last funding round?

Chemestmed's most recent funding round was Grant on June 10, 2026.

Who are the main investors in Chemestmed?

Key investors in Chemestmed include European Innovation Council.

Will Chemestmed IPO soon?

No public IPO plans have been announced for Chemestmed.

How can I track Chemestmed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Chemestmed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTartu
Employee Range7
Year Founded2011
Last FundingJun 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?